Boston, MACIK 16276084 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
39 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Structure Therapeutics Inc | 225.0K | $15.65M | 8.9% | +25.0K | Added |
| 2 | Medline Inc | 300.0K | $12.60M | 7.2% | +300.0K | New |
| 3 | Sofi Technologies Inc | 400.0K | $10.47M | 5.9% | +400.0K | New |
| 4 | Ul Solutions Inc |
| 130.0K |
| $10.25M |
| 5.8% |
| +130.0K |
| New |
| 5 | Insmed Inc | 50.0K | $8.70M | 4.9% | +50.0K | New |
| 6 | Terns Pharmaceuticals Inc | 197.3K | $7.97M | 4.5% | +197.3K | New |
| 7 | Kymera Therapeutics Inc | 100.0K | $7.78M | 4.4% | +100.0K | New |
| 8 | Miami Intl Hldgs Inc | 175.0K | $7.77M | 4.4% | +25.0K | Added |
| 9 | Bridgebio Pharma Inc | 100.0K | $7.65M | 4.3% | −100.0K | Reduced |
| 10 | Solid Biosciences Inc | 1.35M | $7.61M | 4.3% | +1.35M | New |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio